| Advances in breast cancer management and extracellular vesicle research, a bibliometric analysis RHG Teles, RS Yano, NJ Villarinho, AS Yamagata, RG Jaeger, ... Current Oncology 28 (6), 4504-4520, 2021 | 32 | 2021 |
| Effects of long‐term exposure to MST‐312 on lung cancer cells tumorigenesis: Role of SHH/GLI‐1 axis NJ Villarinho, FC Vasconcelos, L Mazzoccoli, MC da Silva Robaina, ... Cell Biology International 46 (9), 1468-1479, 2022 | 4 | 2022 |
| Transcriptomic response to acidosis reveals its contribution to bone metastasis in breast cancer cells AS Yamagata, PP Freire, N Jones Villarinho, RHG Teles, KJM Francisco, ... Cells 11 (3), 544, 2022 | 4 | 2022 |
| Conditioned Medium From Reactive Astrocytes Inhibits Proliferation, Resistance, and Migration of p53‐Mutant Glioblastoma Spheroid Through GLI‐1 Downregulation JH Ribeiro, NJ Villarinho, PV Fernandes, TCLS Spohr, GPF Lopes Journal of Cellular Biochemistry 125 (9), e30637, 2024 | 1 | 2024 |
| Valosin-containing protein (VCP), a component of tumor-derived extracellular vesicles, impairs the barrier integrity of brain microvascular endothelial cells RHG Teles, NJ Villarinho, AS Yamagata, CT Hiroki, MC de Oliveira, ... BBA advances 7, 100130, 2025 | | 2025 |
| Transcriptomic Response to Acidosis Reveals Its Contribution to Bone Metastasis in Breast Cancer Cells. Cells 2022, 11, 544 AS Yamagata, PP Freire, NJ Villarinho, RHG Teles, KJM Francisco, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Effects of MST-312 long-term treatment in the MDR phenotype of non-small cell lung cancer GPF Lopes, FC Vasconcelos, RC Maia, L Mazzoccoli, NJ Villarinho, ... INCA, 2018 | | 2018 |
| Cytotoxic effect of telomerase inhibitor MST-312 in lung cancer cells NJ Villarinho, RC Maia, GMC Longo, FC Vasconcelos, DM Oliveira, ... INCA, 2017 | | 2017 |
| BBA Advances RHG Teles, NJ Villarinho, AS Yamagata, CT Hiroki, MC de Oliveira, ... | | |
Ramon Handerson Gomes TelesUniversity of Santiago de CompostelaVerified email at usc.es
